Catheter Precision, Inc.
VTAK
$3.52
$0.910134.87%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.61% | 9.57% | -4.98% | 27.07% | 140.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.61% | 9.57% | -4.98% | 27.07% | 140.88% |
| Cost of Revenue | 35.29% | 92.00% | 40.00% | 65.22% | 100.00% |
| Gross Profit | 37.81% | 4.59% | -8.25% | 24.05% | 145.12% |
| SG&A Expenses | 13.86% | 27.59% | -33.72% | -50.87% | -53.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.39% | 27.66% | -33.83% | -51.39% | -54.51% |
| Operating Income | -14.48% | -28.50% | 34.58% | 52.47% | 55.97% |
| Income Before Tax | -87.38% | -127.78% | 80.87% | 85.03% | 88.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.83% | -163.08% | 76.42% | 85.03% | 88.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -99.16% | -163.08% | 76.42% | 85.03% | 88.27% |
| EBIT | -14.48% | -28.50% | 34.58% | 52.47% | 55.97% |
| EBITDA | -17.59% | -45.01% | 33.48% | 55.96% | 60.48% |
| EPS Basic | 70.55% | 12.06% | 95.14% | 95.82% | 95.50% |
| Normalized Basic EPS | 76.97% | -543.42% | 67.78% | 83.24% | 81.37% |
| EPS Diluted | 70.55% | 12.06% | 95.14% | 95.82% | 95.50% |
| Normalized Diluted EPS | 76.97% | -543.42% | 67.78% | 83.24% | 81.37% |
| Average Basic Shares Outstanding | 1,153.82% | 786.01% | 495.40% | 150.17% | 182.68% |
| Average Diluted Shares Outstanding | 1,153.82% | 786.01% | 495.40% | 150.17% | 182.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |